Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Diagnoptics Logo
Diagnoptics Growth Score
86
CB Rank
631425
Heat Score
68
Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes.
Founded
obfuscation
Private Groningen, Groningen, The Netherlands11-50 www.diagnoptics.com/
Health Care
Health Diagnostics
Medical Device
Overview

Diagnoptics
Growth Score
86
Heat Score
68

Growth Score86
-2 pts
in past quarter
Heat Score 68
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Diagnoptics

CB Rank
631425
Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes.
Founded
obfuscation
Private Groningen, Groningen, The Netherlands11-50 www.diagnoptics.com/
Health Care
Health Diagnostics
Medical Device

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Andries J. Smit, Ir. Reindert Graaff
About the Company

Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Reader™ - a state of art diagnostic device which can

determine the tissue accumulation of AGEs in 30 seconds.

Phone Number +31 50 589 0612
Contact Email info@diagnoptics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AGE Reader mu
A non-invasive device that measures skin autofluorescence to assess cardiovascular and diabetes risk.
AGE Reader App
An application that generates cardiovascular risk reports based on AGE Reader measurements and stores patient visit data.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 2 Contacts 2

Employee Profiles

Board Members and Advisors

News
Technology
View Tech Report

Monthly Web Visits

1,144
68.98%
 in past month

Active Website Tech Count

5Diagnoptics is actively using 5 technologies for its website, according to BuiltWith. These include Viewport Meta, Common Crawl, and  CommonCrawl Top 5m.
Sub-Organizations
Frequently Asked Questions

Where is Diagnoptics's headquarters? Diagnoptics is located in Groningen, Groningen, The Netherlands.Who are Diagnoptics's competitors? Alternatives and possible competitors to Diagnoptics may include Roche, Abbott, and  Dexcom.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(93c8483 1)
|